Corient Private Wealth’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$612K Buy
2025
Q1
$465K Sell
2024
Q4
$1.08M Buy
2024
Q3
$557K Buy
2024
Q2
$611K Buy
2024
Q1
$527K Buy
2023
Q4
$419K Buy
2023
Q3
$355K Buy
2023
Q2
$288K Sell
2023
Q1
$526K Buy